← back to search

Guanghui Zhou

Guangzhou University of Chinese Medicine · CN
Area of research
Molecular Biology · Orthopedics and Sports Medicine
Research interest
Research focused on Osteoporosis and Traditional Chinese medicine, with related work in Osteoarthritis, Quartile, Bioavailability. Notable publications include 'Guidelines for the diagnosis and treatment of knee osteoarthritis with integrative medicine based on traditional Chinese medicine', 'Efficacy and safety of curcumin therapy for knee osteoarthritis: A Bayesian network meta-analysis', and 'Higher systemic immune-inflammation index is associated with sarcopenia in individuals aged 18–59 years: a population-based study'.
h-index
citations
242
works
18
NIH funding
primary concept
email

Recent publications

Dasatinib and Quercetin alleviate type 2 diabetic osteoporosis by regulating serum metabolite and gut microbiome
Frontiers in Microbiology 2025cited by 3position: middledoi
Gusongan capsule enhances osteogenic differentiation to mitigate bone loss in ovariectomized rats via the TLR2/NF-κB pathway
Phytomedicine 2025cited by 2position: middledoi
Effectiveness and Current Status of Icariin in the Treatment of Rotator Cuff Injury Associated with Osteoporosis
Current Protein and Peptide Science 2025cited by 1position: middledoi
Research progress of plant medicine and Chinese herbal compounds in the treatment of rheumatoid arthritis combined with osteoporosis
Frontiers in Medicine 2024cited by 7position: middledoi
Research Progress of TCM Therapy for Rotator Cuff Injury
Combinatorial Chemistry & High Throughput Screening 2024cited by 3position: middledoi
Guidelines for the diagnosis and treatment of knee osteoarthritis with integrative medicine based on traditional Chinese medicine
Frontiers in Medicine 2023cited by 48position: middledoi
Efficacy and safety of curcumin therapy for knee osteoarthritis: A Bayesian network meta-analysis
Journal of Ethnopharmacology 2023cited by 41position: middledoi
Higher systemic immune-inflammation index is associated with sarcopenia in individuals aged 18–59 years: a population-based study
Scientific Reports 2023cited by 29position: middledoi
Safety, immunogenicity, and efficacy of the mRNA vaccine CS-2034 as a heterologous booster versus homologous booster with BBIBP-CorV in adults aged ≥18 years: a randomised, double-blind, phase 2b trial
The Lancet Infectious Diseases 2023cited by 25position: middledoi
Effects of resveratrol in an animal model of osteoporosis: a meta-analysis of preclinical evidence
Frontiers in Nutrition 2023cited by 16position: middledoi
J-shaped association of serum uric acid concentrations with all-cause mortality in individuals with osteoarthritis: A prospective cohort study
Joint Bone Spine 2023cited by 6position: middledoi
Global Publication Trends and Research Hotspots of the Immune Systemand Osteoporosis: A Bibliometric and Visualization Analysis from 2012 to2022
Endocrine Metabolic & Immune Disorders - Drug Targets 2023cited by 5position: middledoi
Longbie capsules reduce bone loss in the subchondral bone of rats with comorbid osteoporosis and osteoarthritis by regulating metabolite alterations
Frontiers in Medicine 2023cited by 4position: middledoi
Effectiveness of Chinese Herbal Medicine in Postoperative FatigueSyndrome Following Total Joint Arthroplasty or Hip Fracture Surgery:Evidence from Randomized Controlled Trials
Combinatorial Chemistry & High Throughput Screening 2023cited by 3position: middledoi
Increased progranulin as an independent predictive biomarker for poor prognosis in sepsis
Cytokine 2022cited by 10position: middledoi
Effectiveness of Yushen Hezhi therapy for postmenopausal osteoporosis: An overview of systematic reviews of randomized controlled trials
Frontiers in Endocrinology 2022cited by 3position: middledoi
Piperine fast disintegrating tablets comprising sustained-release matrix pellets with enhanced bioavailability: formulation, <i>in vitro</i> and <i>in vivo</i> evaluation
Pharmaceutical Development and Technology 2020cited by 20position: middledoi
Elevated serum Activin A in chronic obstructive pulmonary disease with skeletal muscle wasting
Clinics 2019cited by 16position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Weiyi Yang · Guangzhou University of Chinese Medicine10 papers (2023–2025)Guihong Liang · Guangzhou University of Chinese Medicine10 papers (2023–2025)Jinlong Zhao · Guangzhou University of Chinese Medicine10 papers (2022–2025)Lingfeng Zeng · Guangzhou University of Chinese Medicine9 papers (2023–2025)Jun Liu · Guangzhou University of Chinese Medicine8 papers (2022–2025)Zhuoxu Gu · Guangzhou University of Chinese Medicine6 papers (2023–2025)Jianke Pan · Guangzhou University of Chinese Medicine6 papers (2023–2025)Yaoxing Dou · Guangzhou University of Chinese Medicine5 papers (2023–2024)Bangxin Sha · Guangzhou University of Chinese Medicine4 papers (2023–2023)Kunhao Hong · Guangzhou University of Chinese Medicine4 papers (2023–2023)Xianquan Zhang · Guangzhou University of Chinese Medicine3 papers (2024–2025)Minghui Luo · Guangzhou University of Chinese Medicine3 papers (2023–2025)Hetao Huang · Guangzhou University of Chinese Medicine3 papers (2023–2023)Junzheng Yang · Guangzhou University of Chinese Medicine2 papers (2025–2025) · 2 papers (2019–2022)Xue Wang · Hebei Medical University1 papers (2023–2023)Junzheng Yang · Guangzhou University of Chinese Medicine1 papers (2023–2023)Jun Liu · Guangzhou University of Chinese Medicine1 papers (2025–2025)Ximing Xu · Jiangsu University1 papers (2020–2020)Ying Wang · Guangzhou Medical University1 papers (2023–2023)